ondansetron has been researched along with Hypoglycemia in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To document ondansetron-induced dystonia, hypoglycemia, and seizures in a child." | 7.77 | Ondansetron-induced dystonia, hypoglycemia, and seizures in a child. ( Manchanda, S; Mittal, S; Patel, A; Puliyel, JM, 2011) |
| "The present study was undertaken in order to establish the possible involvement of 5-HT3 serotonergic receptors in the control of basal and/or hypoglycemia-stimulated arginine vasopressin (AVP) and/or oxytocin (OT) secretion." | 7.70 | 5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men. ( Caffarri, G; Capretti, L; Chiodera, P; Coiro, V; Giuliani, N; Magotti, MG; Volpi, R, 1998) |
| "To document ondansetron-induced dystonia, hypoglycemia, and seizures in a child." | 3.77 | Ondansetron-induced dystonia, hypoglycemia, and seizures in a child. ( Manchanda, S; Mittal, S; Patel, A; Puliyel, JM, 2011) |
| "The present study was undertaken in order to establish the possible involvement of 5-HT3 serotonergic receptors in the control of basal and/or hypoglycemia-stimulated arginine vasopressin (AVP) and/or oxytocin (OT) secretion." | 3.70 | 5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men. ( Caffarri, G; Capretti, L; Chiodera, P; Coiro, V; Giuliani, N; Magotti, MG; Volpi, R, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, A | 1 |
| Mittal, S | 1 |
| Manchanda, S | 1 |
| Puliyel, JM | 1 |
| Volpi, R | 1 |
| Chiodera, P | 1 |
| Giuliani, N | 1 |
| Capretti, L | 1 |
| Caffarri, G | 1 |
| Magotti, MG | 1 |
| Coiro, V | 1 |
2 other studies available for ondansetron and Hypoglycemia
| Article | Year |
|---|---|
Ondansetron-induced dystonia, hypoglycemia, and seizures in a child.
Topics: Antiemetics; Child, Preschool; Dystonia; Humans; Hypoglycemia; Male; Ondansetron; Seizures; Serotoni | 2011 |
5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men.
Topics: Adult; Arginine Vasopressin; Humans; Hypoglycemia; Insulin; Kinetics; Male; Ondansetron; Oxytocin; P | 1998 |